BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,368 | -17.2% | 1,600 | 0.0% | 0.02% | -16.0% |
| Q2 2023 | $72,896 | +12.3% | 1,600 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $64,896 | -20.4% | 1,600 | 0.0% | 0.02% | -24.2% |
| Q4 2022 | $81,552 | -5.2% | 1,600 | 0.0% | 0.03% | -15.4% |
| Q3 2022 | $86,000 | -16.5% | 1,600 | 0.0% | 0.04% | -4.9% |
| Q2 2022 | $103,000 | -16.9% | 1,600 | 0.0% | 0.04% | +2.5% |
| Q1 2022 | $124,000 | -9.5% | 1,600 | 0.0% | 0.04% | +5.3% |
| Q4 2021 | $137,000 | +6.2% | 1,600 | 0.0% | 0.04% | +2.7% |
| Q3 2021 | $129,000 | 0.0% | 1,600 | 0.0% | 0.04% | +2.8% |
| Q2 2021 | $129,000 | -4.4% | 1,600 | 0.0% | 0.04% | -14.3% |
| Q1 2021 | $135,000 | +5.5% | 1,600 | 0.0% | 0.04% | +5.0% |
| Q4 2020 | $128,000 | -0.8% | 1,600 | 0.0% | 0.04% | -4.8% |
| Q3 2020 | $129,000 | -6.5% | 1,600 | 0.0% | 0.04% | -14.3% |
| Q2 2020 | $138,000 | +3.0% | 1,600 | 0.0% | 0.05% | -5.8% |
| Q1 2020 | $134,000 | 0.0% | 1,600 | 0.0% | 0.05% | +4.0% |
| Q4 2019 | $134,000 | -4.3% | 1,600 | 0.0% | 0.05% | -12.3% |
| Q3 2019 | $140,000 | +6.9% | 1,600 | 0.0% | 0.06% | +9.6% |
| Q2 2019 | $131,000 | +0.8% | 1,600 | 0.0% | 0.05% | -5.5% |
| Q1 2019 | $130,000 | +23.8% | 1,600 | 0.0% | 0.06% | +7.8% |
| Q4 2018 | $105,000 | -14.6% | 1,600 | 0.0% | 0.05% | 0.0% |
| Q3 2018 | $123,000 | +4.2% | 1,600 | 0.0% | 0.05% | -1.9% |
| Q2 2018 | $118,000 | +13.5% | 1,600 | 0.0% | 0.05% | +10.6% |
| Q1 2018 | $104,000 | +1.0% | 1,600 | 0.0% | 0.05% | -2.1% |
| Q4 2017 | $103,000 | +8.4% | 1,600 | -25.0% | 0.05% | -12.7% |
| Q4 2016 | $95,000 | -8.7% | 2,133 | -2.5% | 0.06% | -6.8% |
| Q3 2016 | $104,000 | +5.1% | 2,188 | 0.0% | 0.06% | 0.0% |
| Q2 2016 | $99,000 | +10.0% | 2,188 | 0.0% | 0.06% | +13.5% |
| Q1 2016 | $90,000 | +80.0% | 2,188 | +68.6% | 0.05% | +92.6% |
| Q4 2015 | $50,000 | +16.3% | 1,298 | 0.0% | 0.03% | +8.0% |
| Q3 2015 | $43,000 | -52.7% | 1,298 | 0.0% | 0.02% | -51.0% |
| Q2 2015 | $91,000 | +2.2% | 1,298 | 0.0% | 0.05% | +4.1% |
| Q1 2015 | $89,000 | -20.5% | 1,298 | -14.8% | 0.05% | -15.5% |
| Q4 2014 | $112,000 | +2.8% | 1,524 | 0.0% | 0.06% | -3.3% |
| Q3 2014 | $109,000 | +22.5% | 1,524 | +23.5% | 0.06% | +30.4% |
| Q2 2014 | $89,000 | -12.7% | 1,234 | -10.8% | 0.05% | -16.4% |
| Q1 2014 | $102,000 | +6.2% | 1,384 | 0.0% | 0.06% | +5.8% |
| Q4 2013 | $96,000 | -95.5% | 1,384 | -95.8% | 0.05% | -96.0% |
| Q3 2013 | $2,155,000 | -6.7% | 32,802 | -1.7% | 1.30% | -11.7% |
| Q2 2013 | $2,310,000 | – | 33,355 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |